Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha

NCT01073436 · clinicaltrials.gov ↗

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Closed prematurely due to low accrual.

Conditions

Chronic Myeloid Leukemia

Interventions

OTHER: Discontinuation of therapy

Sponsor

University of Michigan Rogel Cancer Center